Scholarlink

Objectives <p>The aim of this survey was to obtain a snapshot of the real-life practice of locoregional treatment in hepatocellular carcinoma patients, which can sometimes greatly diverge from the guidelines.</p> Materials and methods <p>This survey, elaborated before and during the Mediterranean Interventional Oncology Live (MIO-Live) 2024 congress, was based on a pre-congress questionnaire and an in-congress questionnaire via a voting system during an expert panel discussion simulating a multidisciplinary tumor board for hepatocellular carcinoma patients. Voters and the expert panel were from various centers all over the world.</p> Results <p>Eighty participants answered the pre-congress questionnaire. Seventy-two, 64, and 78 participants answered the in-congress questionnaire through the voting system for the early-, intermediate-, and advanced-stage HCC categories, respectively. Trends in locoregional treatment choice and application were obtained and confronted with current guidelines for hepatocellular carcinoma treatment.</p> Conclusions <p>The survey showed how hepatocellular carcinoma patients are treated with locoregional techniques in real-life practice, highlighting the difference that can arise between multidisciplinary tumor board decisions and current guidelines.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Think tank on locoregional treatments in hepatocellular carcinoma: a snapshot of real-life practice

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月15日

查看全文
  • Roberto Iezzi,
  • Andrea Contegiacomo,
  • Alessandro Posa,
  • Anna Rita Scrofani,
  • Bianca Rocco,
  • Alessandro Maresca,
  • Irene Bargellini,
  • Tiago Bilhim,
  • Laura Crocetti,
  • Francesco De Cobelli,
  • Antonio Gasbarrini,
  • Shraga Nahum Goldberg,
  • Pierleone Lucatelli,
  • Fernando Gómez Muñoz,
  • Maurizio Pompili,
  • Dimitrios Filippiadis

摘要

Objectives

The aim of this survey was to obtain a snapshot of the real-life practice of locoregional treatment in hepatocellular carcinoma patients, which can sometimes greatly diverge from the guidelines.

Materials and methods

This survey, elaborated before and during the Mediterranean Interventional Oncology Live (MIO-Live) 2024 congress, was based on a pre-congress questionnaire and an in-congress questionnaire via a voting system during an expert panel discussion simulating a multidisciplinary tumor board for hepatocellular carcinoma patients. Voters and the expert panel were from various centers all over the world.

Results

Eighty participants answered the pre-congress questionnaire. Seventy-two, 64, and 78 participants answered the in-congress questionnaire through the voting system for the early-, intermediate-, and advanced-stage HCC categories, respectively. Trends in locoregional treatment choice and application were obtained and confronted with current guidelines for hepatocellular carcinoma treatment.

Conclusions

The survey showed how hepatocellular carcinoma patients are treated with locoregional techniques in real-life practice, highlighting the difference that can arise between multidisciplinary tumor board decisions and current guidelines.